Clinical Trial For Type 2 Diabetes Patients
Annapolis Internal Medicine is excited to announce a new clinical trial for patients with Type 2 diabetes. People recently diagnosed with Type 2 diabetes are at higher risk for developing pancreatic cancer. Bluestar Genomics is studying a new blood test to identify pancreatic cancer in people with recently diagnosed Type 2 diabetes.